{"disease":{"id":"nystagmus-acquired","name":"nystagmus acquired"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05176015","title":"Nystagmus Assessment for Patients Consulting in the Emergency Department for Acute Vertigo","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"CHU de Quebec-Universite Laval","has_results":false},{"nct_id":"NCT02189720","title":"Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Catalyst Pharmaceuticals, Inc.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}